Riximyo-H-C-PSUSA-00002652-202111
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
scientific-discussion-variation
medication.label.permit_number
EMA/592634/2022
medication.label.permit_validity
First published: 2022-08-31T15:59:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live